“…Cells derived from FA patients are characterized by chromosomal instability and hypersensitivity to ICL-inducing agents and, in at least some cases, to ionizing radiation (IR) (Carreau et al, 1999;Garcia-Higuera et al, 2001;Gatti, 2001;Digweed et al, 2002). The disease has a high degree of heterogeneity, with 11 known complementation groups (FA-A, B, C, D1, D2, E, F, G, I, J and K) (Levitus et al, 2003) and eight genes (FANCA, C, D1/BRCA2, D2, E, F, G, L) cloned thus far (Strathdee et al, 1992;Lo Len Foe et al, 1996; The Fanconi anaemia/breast cancer Consortium, 1996;de Winter et al, 1998de Winter et al, , 2000aTimmers et al, 2001;Howlett et al, 2002;Meetei et al, 2003).…”